AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs Dow Jones · Markets 5m ago
Earnings call transcript: Vail Resorts posts modest beat in Q4 2026 as shares slip Investing.com · News 19m ago
Glucotrack announces amendments to warrant and note agreements, repays bridge notes Investing.com · News 22m ago
Newbury Street II Acquisition Corp sets deadline for shareholder proposals ahead of extraordinary meeting Investing.com · News 25m ago